Axon Enterprise Inc vs Progressive Corp — how do they compare? Axon Enterprise Inc trades at $605.77 (market cap $51.69B), while Progressive Corp trades at $209.22 (market cap $123.45B). The key difference: Progressive Corp is far larger — about 2.4× Axon Enterprise Inc's market cap, and Progressive Corp pays a 6.55% dividend while Axon Enterprise Inc pays none. Which is the better fit depends on your goals.
| AXON | PGR | |
|---|---|---|
Market Cap | $51.69B | $123.45B |
Sector | Technology | Financials |
52-Week High | $791.62 | $252.68 |
52-Week Low | $345.94 | $190.40 |
Enterprise Value | $52.83B | $131.66B |
Dividend Yield | — | 6.55% |
Signals from Pluang's Aura AI — not financial advice
Axon Enterprise (AXON) trades at $616.97, up 3.46% in the last 24 hours, showing strong momentum with a bullish technical signal and consistent earnings beats. The stock is near its pivot point of $629, with support at $616 and resistance at $649. Revenue grew 35% year-over-year in Q2 2026, driven by AI and counter-drone offerings, though high valuation multiples like a P/E of 265.13 and P/S of 16.35 reflect premium pricing. Analyst consensus is strongly bullish with an $685 price target, but gross margin compression and elevated multiples pose risks.
Outlook remains positive given robust growth and AI adoption, but investors face valuation risks and margin pressures. The stock offers upside to consensus targets if execution continues, yet any growth slowdown could trigger significant multiple contraction. Key catalysts include Q3 2026 earnings and AI-driven contract expansions.
Progressive (PGR) trades at $213.95, down 0.64% on the day, with a bullish technical outlook supported by moving averages. The company shows strong fundamental performance with revenue growing from $49.6B in 2022 to $87.6B in 2025 and net income reaching $11.3B. Recent Q2 2026 earnings beat expectations at $4.85 per share, though the combined ratio widened to 87.1%, indicating potential growth trade-offs. Analyst consensus price target stands at $231.20 with 37% buy ratings.
PGR presents a compelling investment case with reasonable valuation (P/E 10.65) and strong profitability (ROE 34.94%), though investors face risks from competitive pressures and potential margin compression as the company expands its bundled insurance offerings. The stock offers 8% upside to consensus target with balanced risk-reward profile.
Trailing returns across standard periods
Latest headlines on both assets
Axon develops technology and weapons for law enforcement and military use. Its ecosystem includes TASER devices, body cameras, and Evidence.com, a cloud-based platform for digital evidence management.
Read more on AXON →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →